Table 1.
Characteristics of the Participants
| AML Patients | Healthy Individuals | p | ALL Patients | Healthy Individuals | p | |
|---|---|---|---|---|---|---|
| Age (years) | 45±18 | 42±12 | 0.246 | 21±20 | 23±16 | 0.591 |
| Gender (man/women) | 37/19 | 36/23 | – | 24/16 | 23/22 | – |
| GLU(mmol/L) | 5.00±1.07 | 5.19±0.76 | 0.306 | 5.12±1.12 | 5.01±0.72 | 0.654 |
| LDH(U/L) | 194.5 | 199 | 0.680 | 281 | 302 | 0.398 |
| TBA(mmol/L) | 5.95±10.84 | 4.51±7.23 | 0.417 | 9.88±15.01 | 3.47±2.69 | 0.006 |
| CG(mg/L) | 3.33±7.90 | 2.18±2.10 | 0.342 | 4.02±4.43 | 3.87±4.10 | 0.025 |
| NEFA(mmol/L) | 0.40±0.24 | 0.44±0.21 | 0.438 | 0.41±0.31 | 0.41±0.24 | 0.915 |
| sdLDL(mmol/L) | 0.79±0.48 | 0.92±0.50 | 0.234 | 0.49±0.29 | 0.63±0.44 | 0.145 |
| apoE(mg/L) | 4.83±0.81 | 5.23±0.87 | 0.024 | 6.10±2.58 | 5.54±1.32 | 0.228 |
| TC(mmol/L) | 4.32±1.05 | 5.24±0.88 | <0.001 | 3.72±1.11 | 4.54±0.95 | 0.001 |
| HDL-C(mmol/L) | 0.97±0.26 | 1.33±0.33 | <0.001 | 1.05±0.46 | 1.47±0.39 | <0.001 |
| LDL-C(mmol/L) | 2.46±0.79 | 2.87±0.67 | 0.004 | 1.87±0.71 | 2.44±0.59 | <0.001 |
| TG(mmol/L) | 2.01±1.31 | 1.49±0.90 | 0.018 | 1.792±1.18 | 1.25±0.75 | 0.014 |
| apoA1(g/L) | 1.05±0.25 | 1.24±0.21 | <0.001 | 1.00±0.23 | 1.27±0.25 | <0.001 |
| apoB100(g/L) | 0.80±0.25 | 0.81±0.20 | 0.912 | 0.63±0.21 | 0.73±0.20 | 0.044 |
| Lp(a)(mg/L) | 76 | 169 | 0.172 | 95 | 68 | 0.516 |
| WBC (10^9/L) | 9.09±16.05 | 6.36±1.28 | 0.20 | 24.61±62.72 | 6.42±1.23 | 0.05 |
| RBC (10^12/L) | 3.40±1.00 | 4.86±0.53 | <0.01 | 3.26±0.69 | 4.81±0.42 | <0.01 |
| MCV (fL) | 94.06±6.34 | 91.25±6.33 | 0.02 | 94.73±18.60 | 89.83±3.84 | 0.09 |
| HGB (g/L) | 104.04±30.03 | 146.24±17.85 | <0.01 | 99.18±23.39 | 142.20±12.19 | <0.01 |
| NEUT% | 51.65±23.65 | 58.76±5.66 | 0.02 | 51.76±24.97 | 56.88±5.37 | 0.18 |
| LYMPH% | 34.13±21.19 | 32.03±4.76 | 0.45 | 34.52±24.35 | 33.91±4.78 | 0.86 |
| MONO% | 11.70±14.15 | 6.35±1.51 | 0.01 | 11.76±11.29 | 6.36±1.58 | 0.01 |
| EO% | 1.68±2.40 | 2.88±1.55 | 0.11 | 1.49±2.21 | 2.31±1.30 | 0.03 |
| BASO% | 0.50±0.42 | 0.58±0.24 | 0.23 | 0.47±0.55 | 0.54±0.22 | 0.42 |
| PLT (10^9/L) | 195.13±164.4 | 249.95±56.33 | 0.01 | 157.93±94.75 | 258.04±47.09 | <0.01 |
| PDW (%) | 10.97±2.26 | 12.43±1.30 | <0.01 | 10.48±1.96 | 12.02±1.42 | <0.01 |
Notes: Characteristics of the 56 AML patients, 29 AML healthy individuals, 40 ALL patients and 37 ALL healthy individuals used in this study.
Abbreviations: GLU, glucose; LDH, lactate dehydrogenase; TBA, total bile acid; CG, cholyglycine; WBC, white blood cell; RBC, red blood cell; MCV, mean corpuscular volume; HGB, hemoglobin; PLT, platelet; PDW, platelet distribution width; MPV, mean platelet volume.